PaceMate, a market leading cardiac data management platform, announced today industry partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions
September 28, 2023
PaceMate Announces Industry Partnership with MedAxiom
September 28, 2023 — PaceMate, a market leading cardiac data management platform, announced today industry partnership…
Read More
Advanced fellowship-trained cardiologist will see patients in Larkspur
September 28, 2023
Pankaj Malhotra, MD Joins MarinHealth Cardiovascular Medicine
September 28, 2023 — MarinHealth today announced that Pankaj Malhotra, MD, a non-invasive cardiologist with additional…
Read More
New workbook is roadmap to providing quality basic and advanced CV care in the home
September 27, 2023
ACC Releases Guide to Home-Based Cardiac Care
September 27, 2023 — The healthcare landscape has undergone rapid changes in recent years, requiring clinicians and…
Read More
Rhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.
September 27, 2023
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service
September 27, 2023 — iRhythm Technologies, Inc.  announced the U.S. launch of its next-generation Zio monitor and…
Read More
Boston Scientific announced the FDA clearance of the AVVIGOTM+ Multi-Modality Guidance System
September 27, 2023
Boston Scientific Announces FDA Clearance of the AVVIGO + Multi-Modality Guidance System
September 27, 2023 — Boston Scientific announced the FDA clearance of the AVVIGOTM+ Multi-Modality Guidance System, a…
Read More
September 27, 2023
HeartBeam Announces Senior Management Team Appointments
September 27, 2023 — HeartBeam, Inc., a Santa Clara, CA-based cardiac technology company, has appointed Richa Gujarati…
Read More
September 27, 2023
Results Presented at Pulmonary Embolism Symposium Show Aidoc Solution Reduces Hospital Stay Duration and Improved Patient Treatment Access
September 27, 2023 — The National PERT Consortium held its 9th Annual Pulmonary Embolism Symposium: “What is Known and…
Read More
Study participants may transition from the rivaroxaban arm to abelacimab in an extension study
September 26, 2023
Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions
September 26, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for…
Read More
Patents cover MyoVista Wavelet Technology utilizing AI for early detection of heart disease
September 26, 2023
HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio
September 26, 2023 —  Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming …
Read More
New research from the Smidt Heart Institute shows that heart attack patients who also had COVID-19 were three times more likely to die in the hospital
September 26, 2023
Study: Heart Attack Outcomes Far Worse for Those With COVID-19
September 26, 2023 — New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a…
Read More
September 26, 2023
Cardiovascular Research Foundation Preps Program for Scientific Symposium, TCT 2023
September 26, 2023 — The Cardiovascular Research Foundation's (CRF) annual scientific symposium, the Transcatheter…
Read More
Xenotransplant surgery in progress. Image courtesy of the University of Maryland School of Medicine 
September 25, 2023
UM Medicine Faculty-Scientists and Clinicians Perform Second Historic Transplant of Pig Heart into Patient with End-Stage Cardiovascular Disease
September 25, 2023 —  After world’s first successful transplant in 2022, also performed at the University of Maryland…
Read More
Company’s artificial intelligence technology shows better results in early detection and patient care
September 25, 2023
New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care Coordination
September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today…
Read More
Smidt Heart Institute investigators say condition, apparent resistant hypertension, is common, and a particular medication may get patients’ disease under control
September 22, 2023
Novel Study Deepens Knowledge of Treatment-Resistant Hypertension
September 22, 2023 — For many patients with hypertension--an elevated blood pressure that can lead to stroke or heart…
Read More
Advanced medical device reprocessor launches free tool to help hospitals quantify the reduction in carbon emissions possible with a proper EP reprocessing program
September 22, 2023
Innovative Health Brings EP Labs’ Carbon Emissions into Focus with New Sustainability Calculator
September 22, 2023 —  Innovative Health, Inc.  launched a new educational initiative and free online tool to help…
Read More
New Board would recognize evolution of cardiology into distinct medical specialty
September 21, 2023
Cardiovascular Organizations Pursue New, Independent Medical Board
September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands…
Read More
Cardiovascular disease remains the leading cause of death for both men and women
September 21, 2023
Low-income Country Cardiac Imaging Procedures Remain Down Post-COVID
September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly…
Read More
Vektor’s leadership team named HRX AbstracX Innovators, presenting groundbreaking studies on CT scar imaging and wall thickness analysis at HRX 2023
September 21, 2023
Vektor Medical Unveils Cutting-Edge, AI-based Arrhythmia Research at HRX 2023
September 21, 2023 — Vektor Medical, developers of the only FDA-cleared technology to accurately map arrhythmias using…
Read More
HeartSciences and Icahn Mount Sinai have also entered into a memorandum of understanding for ongoing cooperation encompassing de-identified data access
September 21, 2023
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming…
Read More
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
September 20, 2023
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients
September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now